Cited by 11Treatment of Major DepressionFunctional Brain Connectivity StudiesNeural and Behavioral Psychology Studies

Multidimensional imaging techniques for prediction of treatment response in major depressive disorder

Open access
Langenecker, Scott A., Klumpp, Heide, Peters, Amy T., Crane, Natania A., DelDonno, Sophie R., Bessette, Katie L., Ajilore, Olusola, Leow, Alex +8 more·2019·Progress in Neuro-Psychopharmacology and Biological Psychiatry

Abstract

A large number of studies have attempted to use neuroimaging tools to aid in treatment prediction models for major depressive disorder (MDD). Most such studies have reported on only one dimension of function and prediction at a time. In this study, we used three different tasks across domains of function (emotion processing, reward anticipation, and cognitive control, plus resting state connectivity completed prior to start of medication to predict treatment response in 13-36 adults with MDD. For each experiment, adults with MDD were prescribed only label duloxetine (all experiments), whereas another subset were prescribed escitalopram. We used a KeyNet (both Task derived masks and Key intrinsic Network derived masks) approach to targeting brain systems in a specific match to tasks. The most robust predictors were (Dichter et al., 2010) positive response to anger and (Gong et al., 2011) negative response to fear within relevant anger and fear TaskNets and Salience and Emotion KeyNet (Langenecker et al., 2018) cognitive control (correct rejections) within Inhibition TaskNet (negative) and Cognitive Control KeyNet (positive). Resting state analyses were most robust for Cognitive control Network (positive) and Salience and Emotion Network (negative). Results differed by whether an -fwhm or -acf (more conservative) adjustment for multiple comparisons was used. Together, these results implicate the importance of future studies with larger sample sizes, multidimensional predictive models, and the importance of using empirically derived masks for search areas.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pnpbp.2018.07.001

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There has been an increasing amount of studies providing evidence that neural activity could function as a biomarker for response to different treatment approaches.

    “there has been an increasing amount of studies providing evidence that neural activity could function as a biomarker for response to different treatment approaches”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Langenecker, S. A., Klumpp, H., Peters, A. T., Crane, N. A., DelDonno, S. R., Bessette, K. L., Ajilore, O., Leow, A., Shankman, S. A., Walker, S. J., Ransom, M. T., Hsu, D. T., Phan, K. L., Zubieta, J.-K., Mickey, B. J., & Stange, J. P.
Affiliations
  • University of Michigan (US)
  • University of Illinois Chicago (US)
  • Oregon Health & Science University (US)
  • University of Utah (US)
Corresponding author
Langenecker, Scott A.
Venue
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Published
2019-04
Volume
91
Pages
38-48
ISSN
0278-5846 (ISSN-L)
OpenAlex
W2884426013
Cited by
11
References
76
Citations by year
2025: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR000433, UL1TR002240)
  • National Institute of Mental Health (K23MH074459, R01MH101487)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
major depressive disorder, treatment response prediction, antidepressant response, duloxetine, escitalopram, emotional processing, reward anticipation, cognitive control, resting-state functional connectivity, inhibition, multiple testing correction
MeSH terms
Duloxetine Hydrochloride, Adult, Antidepressive Agents, Brain, Major Depressive Disorder, Emotions, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Photic Stimulation, Predictive Value of Tests, Psychomotor Performance, Citalopram, Treatment Outcome, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review